APPLICATION
ANDA206846
TYPE
ANDA
ORIGINAL APPROVAL
2015-07-13
LATEST ACTION
2023-05-24
ROUTE
INTRAMUSCULAR, INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
ONDANSETRON HYDROCHLORIDEPrescription
ONDANSETRON HYDROCHLORIDE EQ 2MG BASE/ML · INJECTABLE · INJECTION
Approval history
2023-05-24Labeling · Supplement 8 · standardAP
2021-10-01Labeling · Supplement 7 · standardAP
2021-10-01Labeling · Supplement 2 · standardAP
2015-07-13UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.